Health Care Rally Sends Eli Lilly Shares Higher
A recent surge in health care stocks has propelled LLY shares upward, reflecting investor optimism about Eli Lilly's future in the industry.
Latest news and analysis for Eli Lilly (LLY).
A recent surge in health care stocks has propelled LLY shares upward, reflecting investor optimism about Eli Lilly's future in the industry.
Eli Lilly's Q4 2025 performance outperformed the Russell 1000, showcasing resilience amid market volatility. What does this mean for LLY's future?
LLY's recent Phase 3b trial results for Taltz and Zepbound could significantly impact its market position. Investors should take note of this development.
A significant $2.93 billion investment from JPMorgan Chase into Eli Lilly (LLY) demonstrates strong confidence in its future growth potential.
LLY experiences a surge as legal concerns mount around competitor Hims offering a low-cost version of a competing product. Find out more.
LLY faces a significant shift as two board members exit. This analysis explores the implications for Eli Lilly shareholders.